AMASS Version 4 Featured at the 2nd Annual AMR Conference 2026, Ubon Ratchathani
AMASS version 4.0
On 31 July 2026, Sunpasitthiprasong Hospital and the Ubon Ratchathani Provincial Public Health Office hosted the 2nd Annual Academic Conference on Rational Antimicrobial Use, themed "The New Era of AMR: Smart Integration, Simple Solution," bringing together physicians, pharmacists, and laboratory staff who work on AMR — with AMASS Program Version 4 featured throughout the day. Prof. Direk Limmathurotsakul, AMASS project leader, co-led the afternoon hands-on workshop on implementing AMASS Version 4.0 Organized by the Sunpasitthiprasong Hospital AMR team and the AMASS team, the event guided participants through data analysis, interpretation, and reporting with AMASS Version 4, alongside sessions on microbiology's role in AWaRe integration, infection prevention and control, and antimicrobial de-escalation.
Photo: Sunpasitthiprasong Hospital organizer

Congratulations to Dr Direk Limmathurotsakul, our AMASS project leader, who has been awarded the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology.
The prize recognizes his pioneering research on melioidosis and antimicrobial resistance — work that has helped shape public health practice in Thailand and beyond. By turning microbiological and hospital data into actionable evidence, Dr Direk has advanced how these threats are understood, tracked and tackled, strengthening surveillance and informing policy at both national and international levels.
This is a proud moment for the whole AMASS team, and a fitting recognition of research that translates science into real-world action to protect patients. Congratulations, Dr Direk!
Source: UNESCO — "Direk Limmathurotsakul awarded the 2026 UNESCO-Carlos J. Finlay Prize for Microbiology."
Full article and photo: https://www.unesco.org/en/articles/direk-limmathurotsakul-awarded-2026-unesco-carlos-j-finlay-prize-microbiology?hub=66925
Photo courtesy of UNESCO.

AMASS Featured in the FAILSAFE Online Workshop
AMASS version 4.0
The AMASS team joined the online workshop "Exploring AMASS for AMR Surveillance," hosted under the FAILSAFE project. Prof. Direk Limmathurotsakul served as the instructor, introducing participants to AMASS and demonstrating how it can strengthen antimicrobial resistance (AMR) surveillance using routine hospital data. The session also showcased the new features in AMASS version 4.0, including expanded reporting on bloodstream infections and the new fungemia (fungal bloodstream infection) epidemiology report.
Link: https://cmm-failsafe.com/workshop-exploring-amass-for-amr-surveillance/

The two days’ workshop onsite for AMASS 4.0
AMASS version 4.0
AMASS team, in collaboration with the ministry of Public Health Thailand, organized the online meeting for introduction the AMASS 4.0 to all participants hospitals in Thailand. 
AMASS 4.0 implemented in 134 hospitals in Thailand
AMASS version 4.0
AMASS team, in collaboration with the ministry of Public Health Thailand, organized the online meeting for introduction the AMASS 4.0 to 134 hospitals in Thailand.

AMASS version 4.0 is now available to download
AMASSv4.0 additionally includes 3 annexes for antimicrobial use (AMU), epidemiology of bloodstream infection, and AMASS-Fungi
The current version of the AMASS application provides the updates including.
1. We have added 3 annexes including
- Annex D: AMU
- Annex E: Epidemiology of bloodstream infection
- Annex F: AMASS-FUNGI (i.e. fungal infection)
2. We have improved Annex A report by reporting notifiable bacterial infections based on (a) microbiology data and (b) hospitalized patient information
3. We have left processed data files (containing patient identifiers) in the folder named "Report_with_patient_identifiers" so that users can use the processed data files for any further analysis and internal usage after using the AMASS.
4. We have left summary files (no patient identifiers) including AMR surveillance report, supplementary data reports for annex B - D, and other summary data files in the folder named "ResultData" so that users can use/share these summary results for any further analysis and internal/external usage after using the AMASS.
5. We have expanded and updated 4 dictionary files including (a) dictionary for hospital admission data, (b) dictionary for microbiology data, (c) dictionary for wards and (d) dictionary for drug data files
6. We have allowed wildcard mapping to values in dictionaries for microbiology and drug data
7. We have improved python version for technical enhancement
|